Brookfield Corp’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-77,642
Closed -$3.56M 668
2022
Q4
$3.56M Sell
77,642
-22,224
-22% -$1.02M 0.01% 312
2022
Q3
$4.84M Buy
99,866
+49,995
+100% +$2.42M 0.02% 281
2022
Q2
$1.96M Buy
+49,871
New +$1.96M 0.01% 402